BAT review points to challenge for policymakers
June 1, 2021
A BAT-backed review of the latest scientific studies on vaping has underlined the need for manufacturers and policy makers to combat myths around vaping.
It highlights a rise in – incorrect – fears among individuals in the UK, EU and US that vaping is more harmful than smoking. According to population modelling studies cited in the review, a significant reduction in premature deaths could be achieved if current smokers switched exclusively to vaping rather than continuing to smoke. These modelling studies use population data and simulations to project the health-related outcomes associated with the long-term risks of smoking versus vapour use over time.
The review brings together 10 years of studies and brings together 300 peer-reviewed scientific papers and other evidence published by an estimated 50 institutions over the past decade.
Dr. David O’Reilly, director of scientific research at BAT, commented: “This paper is a comprehensive summary of more than 300 peer-reviewed scientific papers and other evidence published by an estimated 50 institutions over the past decade.
“The scientific evidence is clear – but consumer misperceptions remain. In England and the United States, only one in three adults is aware that there is scientific evidence available, including from leading public health authorities, that supports the conclusion that vaping is less harmful than smoking.”
